Bio-Techne (TECH) Revenue — Quarter Ended Sep 30, 2025
Revenue declined in the current quarter compared to both the prior quarter and the same quarter last year. The decrease from the preceding quarter was more pronounced than the year-over-year decline.
Key takeaway
Quarter ended Sep 30, 2025 · FY2026 Q1
Revenue declined in the current quarter compared to both the prior quarter and the same quarter last year. The decrease from the preceding quarter was more pronounced than the year-over-year decline.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$286.6M
Revenue reported for this quarter.
Quarter-over-quarter
-9.6%
Change from the immediately preceding quarter.
Year-over-year
-1.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$1.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $297M | +9.0% |
| Mar 31, 2025 | $316.2M | +4.2% |
| Jun 30, 2025 | $317M | +3.5% |
| Sep 30, 2025 | $286.6M | -1.0% |
Revenue performance
The reported revenue for the quarter was lower than the immediately preceding quarter, continuing a downward trend from the prior period's level.
Quarterly comparison
Compared to the same quarter one year earlier, revenue was slightly lower. The sequential decline from the preceding quarter was larger than the year-over-year change.
What to watch
The filing context notes a significant future cash obligation related to an acquisition, which may affect liquidity.